Replicative Senescence in the Immune System: Impact of the Hayflick Limit on T-Cell Function in the Elderly  by Effros, Rita B.
Am. J. Hum. Genet. 62:1003–1007, 1998
1003
HUMAN GENETICS ’98: AGING AND SENESCENCE
Replicative Senescence in the Immune System: Impact of the Hayflick
Limit on T-Cell Function in the Elderly
Rita B. Effros
Department of Pathology and Laboratory Medicine, University of California Los Angeles, School of Medicine, Los Angeles
Gerontologists, lured by the prospect of understanding
the cellular events that underlie the gross features of
human aging, are focusing increasingly on replicative (or
cellular) senescence. The term “replicative senescence”
describes the irreversible state of growth arrest experi-
enced by all mitotically competent cells of human origin
following a fairly predictable number of cell divisions in
culture. First identified in human fetal fibroblasts by
Hayflick, replicative senescence, or the so-called Hay-
flick limit, results from an intrinsic natural barrier to
unlimited cell division exhibited by all normal somatic
cells.
The characteristics of replicative senescence have been
explored in a variety of cell types (reviewed in Smith
and Smith 1996; see also Be´rube´ et al. 1998 [in this
issue]), but only recently has this model been applied to
the immune system. Ironically, the Hayflick limit may
be particularly deleterious for immune cells, since the
ability to undergo rapid clonal expansion is absolutely
essential to their function. The decline of T-cell immune
function during aging suggests that T cells might be an
ideal system in which to explore the potential role of
replicative senescence during in vivo aging. Well-char-
acterized cell surface markers, signal transduction path-
ways, and functional traits further enhance the potential
utility of T cells as a model system, both to elucidate
the process of replicative senescence itself and to assess
its physiological consequences.
This review will summarize the results of research on
T-cell replicative senescence in cell culture and will dem-
onstrate that cells from elderly people have undergone
changes in vivo that are similar to those observed in the
cell culture model. I will argue that T-cell replicative
senescence contributes to increased morbidity and mor-
tality during aging and that the proportion of replica-
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tively senescent T cells within individual subjects may
serve as a measure of “immunological age.” The striking
interindividual variation among elderly people in health
status and immune competence underscores the need to
define parameters other than chronological age to iden-
tify individuals at risk of immunodeficiency.
Proliferation Is Essential for Lymphocyte Function
The major cellular components of the immune system
are T and B lymphocytes, cells that derive from hema-
topoietic stem cells within the bone marrow. The intri-
cate genetic mechanism by which lymphocyte antigen
receptors are generated allows a limited number of im-
munoglobulin and T-cell receptor (TCR) gene segments
to create an immune system with an enormous range of
specificities. Briefly, during a lymphocyte’s development,
one member of a set of gene segments is joined to other
gene segments by an irreversible process of DNA recom-
bination. This random series of juxtapositions forms a
sequence of gene segments, thereby yielding a receptor
molecule that is unique to that cell. The consequence of
this mechanism is that just a few hundred different gene
segments can combine in a variety of ways to create
thousands of receptor chains. The diversity so generated
is further amplified by the pairing of two different
chains, each encoded by distinct sets of gene segments,
to form a functional antigen receptor. By these mecha-
nisms, a small amount of genetic material is utilized to
generate x108 different specificities. Each lymphocyte
bears many copies of its antigen receptor, and, once gen-
erated, the receptor specificity of a lymphocyte does not
change. Thus, only one specificity can be expressed by
a single lymphocyte and its progeny (Janeway and Trav-
ers 1997).
The process of clonal selection is central to adaptive
immunity. When an antigen interacts with receptors ex-
pressed on a mature lymphocyte, that lymphocyte be-
comes activated and starts dividing, giving rise to a clone
of identical progeny bearing identical receptors for an-
tigen. Antigen specificity is thereby maintained as the
dividing cells continue to proliferate and differentiate
into effector cells. Once antigen is cleared, a small num-
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ber of memory cells persist, all bearing the same antigen
receptor. When the same antigen is encountered again,
the process of activation and clonal expansion is
repeated.
The exquisite specificity of each lymphocyte results in
the ability of the organism to respond to the nearly in-
finite number of foreign antigens that could be encoun-
tered over a lifetime. However, because of the enormous
repertoire of responding immune cells, the number of
cells that can recognize and respond to any single antigen
is extremely small. Thus, to generate a sufficient quantity
of specific effector cells to fight an infection, an activated
lymphocyte must proliferate extensively before its prog-
eny differentiate into effector cells. For this reason, a
limitation on the process of cell division could poten-
tially have devastating consequences on immune
function.
To analyze the proliferation systematically, human T
cells derived from peripheral blood of healthy young
adult donors are propagated in cell culture by repeated
stimulation with antigen (Abidzadeh et al. 1996 ) or with
appropriate activating antibodies (Levine et al. 1997)
and continuous exposure to the T cell–specific growth
factor, interleukin-2 (IL-2). Because lymphocytes grow
in suspension culture, it is possible to obtain accurate
cell counts and to determine the precise number of pop-
ulation doublings that occur before replicative senes-
cence is reached. The mean number of cumulative pop-
ulation doublings falls consistently between 25 and 40.
This limited range has been reported by several different
investigators who studied either bulk cultures or clonal
populations, and it applies equally to the two subtypes
of T cells (CD4/helper and CD8/cytotoxic; Grubeck-
Loebenstein et al. 1994; Abidzadeh et al. 1996). De-
scriptions of extremely long-lived T-cell cultures are rare,
and in no case has there ever been a report of normal
T cells not undergoing replicative senescence in culture.
The few studies that analyzed cell populations in pu-
tatively “immortal” cultures derived from normal T cells
invariably found karyotypic abnormalities (Engers et al.
1980). Thus, as had been previously demonstrated in
fibroblast studies (Hayflick 1965; Campisi et al. 1995;
Smith and Pereira-Smith 1996; Be´rube´ et al. 1998), rep-
licative senescence is a stringent characteristic of all nor-
mal human T cells (reviewed in Effros and Pawelec
1997).
Genetic Alterations in Senescent T Cells
T cells express a large number of well-characterized
cell surface molecules. These include antigen receptors;
markers whose expression signifies activation; markers
that distinguish naive and memory cells; integrins, ex-
tracellular matrix–receptor molecules that function in
adhesion and migration; and receptors associated with
helper versus cytotoxic function. Using monoclonal an-
tibodies in combination with flow cytometry, the ex-
pression of a variety of these markers has been shown
to be identical between early-passage cultured T cells
and cultures that had completed their “programmed”
number of cell divisions and had reached senescence (re-
viewed in Effros and Pawelec 1997).
In light of the stable expression of virtually all T-cell
markers tested over the entire proliferative “lifespan” in
culture, it is particularly noteworthy that there is one
cell surface molecule—CD28—whose expression is dra-
matically affected by senescence. It has been shown that,
with increasing number of population doublings in cul-
ture, there is a progressive decrease in the proportion of
T cells expressing CD28, so that in senescent cultures,
195% of the cells are CD28 (Effros et al. 1994a).
CD28 is a 44-kD disulfide-linked homodimer ex-
pressed constitutively on the majority of mature T cells
whose signaling is essential for full T-cell activation. Li-
gation of the T-cell antigen receptor without costimu-
lation by CD28 ligands, such as the “B7” proteins on
the surface of antigen-processing cells, results in the in-
ability to proliferate. CD28 signal transduction results
in IL-2 gene transcription, expression of the IL-2 recep-
tor, and the stabilization of a variety of cytokine mes-
senger RNAs (June et al. 1994). CD28 has additional
biological functions, which include mediation of pro-
tective effects against septic shock in vivo, influencing
the class of antibodies produced by B cells, and en-
hancing T-cell migration and homing (Shimizu et al.
1992).
One of the newly identified roles of CD28 is its pu-
tative involvement in augmenting the induction of the
enzyme telomerase (Weng et al. 1996; see also Be´rube´
et al. 1998). Telomerase is a specialized reverse tran-
scriptase that functions to extend telomere sequences at
the ends of linear chromosomes. In the absence of te-
lomerase, telomeres, the repetitive DNA sequences on
the ends of chromosomes, shorten with each cell division
(Harley et al. 1990). Telomerase activity has been de-
tected in 190% of human tumors and is believed to
enable such cells to divide indefinitely (Shay and Wright
1996). Conversely, telomerase is absent from most nor-
mal somatic cells, leading to the hypothesis that telomere
shortening is causally related to replicative senescence.
Indeed, a landmark event in the field of replicative se-
nescence was the recent validation of the telomere hy-
pothesis of cellular aging. In an elegant series of exper-
iments, Bodnar et al. (1998) demonstrated that gene
transfer of a component of telomerase into normal fi-
broblasts allowed the cells to continue cell division in-
definitely and avoid telomere shortening. The transfected
cells appear normal and show no signs of transforma-
tion, reinforcing the idea that tumor development is a
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multistage process in which telomerase induction is a
necessary, but not sufficient, component.
The relationship of telomeres , telomerase, and se-
nescence is more complex in T lymphocytes than in fi-
broblasts. Lymphocytes differ from fibroblasts and most
other normal somatic cells in that, under certain circum-
stances, they exhibit telomerase activity levels similar to
those observed in tumor cells. For example, high levels
of telomerase activity, further enhanced by CD28 sig-
naling, are observed on T-cell activation (Bodnar et al.
1996; Weng et al. 1996). In addition, telomerase activity
has been documented in developing T cells within the
thymus and in lymphoid organs (June et al. 1995). Nev-
ertheless, despite initially high levels of telomerase ac-
tivity, T cells eventually do senesce in culture, reaching
the same 5–7-kb terminal restriction fragment (TRF)
length (Vaziri et al. 1993) that is characteristic of fibro-
blasts, a cell type that never expresses telomerase. These
findings suggest that T-cell senescence might be fore-
stalled or even reversed if telomerase could be manip-
ulated properly.
T-cell senescence in culture is associated with addi-
tional changes in gene expression. For example, in re-
sponse to a mild heat shock, production of the major
mammalian stress protein, Hsp70, is significantly re-
duced in senescent T cells compared to quiescent early-
passage cells. The lower protein levels are caused by
reduced transcription of the Hsp70 gene (Effros et al.
1994b). This change represents a potentially important
defect in view of the involvement of the Hsp70 family
of cytoplasmic proteins in the response to oxidative
stress, viral infection, and the pathways of antigen pro-
cessing and presentation. Replicative senescence in T
cells also affects the precisely orchestrated series of steps
involved in programmed cell death. Mild heat stress,
low-dose gamma irradiation, and antibodies to the
T-cell receptor and to the Fas antigen can all initiate
apoptosis in early-passage T cells, but this response is
dramatically blunted in senescent cultures, where higher
levels of the apoptosis protective protein, Bcl2, accu-
mulate (R. B. Effros, unpublished data). A final change
in gene expression documented for senescent T-cell cul-
tures is the reexpression of the CD4 marker on mature
CD8 T cells. T cells with this “double positive” (CD4
CD8) phenotype have also been observed to increase
with age in vivo (R. B. Effros, unpublished data).
T-Cell Replicative Senescence Occurs In Vivo
The Holy Grail of replicative senescence studies has
been to demonstrate that aging in vivo is accompanied
by the accumulation of cells, showing all the character-
istics of replicative senescence identified in cell culture.
Information of this type would provide strong evidence
that the complex process of biological aging is somehow
reflected in the in vitro model of cellular aging. Our
identification of loss of CD28 gene expression as a
marker of T-cell senescence in vitro therefore provided
an unparalleled opportunity to test whether similar cells
accumulate during aging in vivo.
We measured the proportion of peripheral blood T
cells expressing the CD28 costimulatory molecule in do-
nors of different ages. Previous studies had documented
that 99% of all T cells in neonates express CD28 (Azuma
et al. 1993). Our own studies demonstrated that CD28
expression on peripheral blood T cells decreases pro-
gressively with age, reaching levels as low as 45%
CD28 T cells in some centenarians (Effros et al.
1994a). The possibility that T-cell replicative senescence
occurs in vivo was also addressed in telomere studies.
Telomere length measurements of peripheral blood lym-
phocytes of subjects ranging from newborn to age 100
years show a progressive shortening to the same 5–7-kb
TRF length observed in T cells that had reached senes-
cence in culture (Vaziri et al. 1993). Moreover, by flow-
cytometric cell sorting of T cells derived from peripheral
blood samples into CD28 and CD28 fractions, we
and others have shown that CD28 T cells have shorter
telomeres than do CD28 T cells from the same donor,
indicating a distinct replicative history for the two cell
populations (Effros et al. 1996; Monteiro et al. 1996).
To determine the proliferative potential of the putatively
senescent lymphocytes, sorted populations of CD28
and CD28 T cells were stimulated with mitogens. Ex-
periments of this sort have repeatedly shown that
CD28 T cells have minimal proliferative capacity, even
when cultured with stimuli that do not require binding
to the TCR or CD28. Thus, in vivo aging is associated
with a progressive increase in a population of T cells
with the key characteristics of senescent T-cell cul-
tures—namely, a loss of CD28 cell surface expression,
shortened telomeres, and an inability to proliferate.
Increased proportions of CD28 T cells have been
documented in other clinical situations in addition to
aging. For example, in HIV-infected persons, X50% of
the peripheral blood T cells lack CD28 expression, and
this value exceeds 65% within the CD8 T-cell subset.
Telomere measurements of sorted CD8 CD28 T cells
showed such cells to have the 5–7-kb TRF size observed
in centenarians. Moreover, such T cells increase over
time in individual donors and correlate directly with
disease progression. The accelerated accumulation of T
cells with characteristics of replicative senescence in HIV-
infected individuals suggests that immune exhaustion, a
hallmark of AIDS, may be caused in part by the Hayflick
limit.
Interestingly, in both aging and HIV infection, the ma-
jority of CD28 T cells are in the CD8 subset, the
cell type mainly responsible for the immune control over
viral infections and tumor progression. CD8 T-cell se-
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nescence may therefore partially account for the clinical
observations of increased susceptibility to viral infec-
tions and cancer in both of these cohorts. Interestingly,
similar clinical findings suggestive of diminished T-cell
function have been reported in individuals with Down
Syndrome (DS). DS, a congenital condition of complete
or partial trisomy 21, is characterized by multiple signs
of early senescence, and individuals with DS have in-
creased proportions of CD8 T cells and greatly en-
hanced susceptibility to viral and bacterial infections and
acute leukemia (Cuadrado and Barrena 1996). Consis-
tent with these clinical observations, accelerated telo-
mere shortening has been documented in peripheral
blood lymphocytes from DS versus age-matched controls
(Vaziri et al. 1993).
The occurrence of replicative senescence in vivo may
offer an explanation for many of the observations re-
garding immunosenescence. Numerous investigators
have demonstrated that one of the major immune
changes associated with aging is a decline in T-cell pro-
liferation (Murasko et al. 1990). A second feature of the
aging immune system is an increase in the ratio of mem-
ory to naive T cells, with the greatest proliferative deficit
present in the memory cells (Miller 1994). It is also
within the memory population that the most dramatic
decline in calcium signaling occurs. Clearly, the cells that
have reached replicative senescence in long-term culture
are memory cells. They have been repeatedly stimulated
to divide both with specific antigen as well as exogenous
IL-2. Furthermore, 199% of the cells in a senescent cul-
ture express the CD45RO antigen, the marker for mem-
ory cells. This suggests that the memory T cells in an
aged individual that show reduced proliferative potential
may arise in vivo by the same mechanism as senescent
cells emerging in long-term cultures. If senescent cells
that arise in vivo are resistant to apoptosis, like their in
vitro counterparts, their presence might compromise ho-
meostatic control over the peripheral T-cell pool (Rocha
et al. 1989). By remaining in the circulation instead of
undergoing programmed cell death, senescent T cells po-
tentially prevent renewal of the T-cell pool with more
functional T cells.
In both aging and chronic HIV infection, replicative
senescence has been observed mainly within the cyto-
toxic (CD8) versus helper (CD4) T-cell subset, pos-
sibly as a result of excessive stimulation during acute or
chronic viral infections. CD8 T cells are “pro-
grammed” to recognize peptides derived from endoge-
nously processed proteins, such as the proteins synthe-
sized in virally infected cells. The viral peptides are
processed and presented on the cell surface of an infected
cell in conjunction with class I major histocompatability
complex molecules. The presence of high proportions of
circulating CD8 T cells showing characteristics of rep-
licative senescence suggests that virus-specific T cells may
be periodically restimulated in vivo to undergo prolif-
eration. Examples of antigens that can provoke repeated
or chronic stimulation of memory T cells are latent vi-
ruses (Epstein-Barr virus), pathogens with cross-reactive
T-cell epitopes (e.g., influenza A; Effros et al. 1977), or
immunogenic self-antigens. The result of this repeated
stimulation would be that the progeny of certain clones
of memory T cells eventually reach a state of replicative
senescence. Consistent with this possibility, oligoclonal
expansions of memory CD8 T cells have been docu-
mented in elderly donors. The expanded T cells are rem-
iniscent of T cells that reach senescence in culture, in
that they are in an activated state, they lack CD28 ex-
pression, and they are unable to undergo proliferation
(Posnett et al. 1994). In addition to the activation of
CD8 T cells in an antigen-specific manner, increased
CD8 T-cell turnover during acute viral infections has
also been documented for T cells that are not involved
in the specific antiviral response (Tripp et al. 1994). This
so-called bystander stimulation, which preferentially af-
fects CD8 T cells, can be mimicked experimentally in
mice by injection of certain cytokines whose levels nor-
mally increase during actual infections (Tough et al.
1996).
Whatever the underlying mechanism leading to the
presence of high proportions of senescent CD8 T cells
in some elderly persons, the ultimate outcome is that
fewer functional CD8 T cells are available to combat
viral infections and cancer. Thus, T cell replicative se-
nescence may indeed affect lifespan by contributing to
the increased mortality from certain diseases in the eld-
erly. A major unanswered question that requires addi-
tional research is, are there intrinsic factors that may
account for the large variability in the rate of human
aging? One might speculate that telomerase induction
patterns may vary between individuals, or that levels of
Hsp70 or Bcl2 proteins are subject to regulatory mech-
anisms, or even that the expression levels of CD28 or
its ligands may contribute to variability in the aging of
the immune system. These and other possibilities present
exciting challenges for future investigation into the im-
munology and immunogenetics of aging.
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